SecSonar.com

AIM ImmunoTech Inc. (AIM)

AIM ImmunoTech Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

AIM ImmunoTech Inc. (AIM) is a Biotechnology company based in US with a market capitalization of $1.3M. Revenue declined 48.2% year-over-year and free cash flow was negative at -$11M. This page tracks AIM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 21 employees · IPO Nov 2, 1995

Valuation

Valuation & price

$0.25 · as of May 15, 2026 · -97.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$8.72$4.48$0.24Jul 25Dec 25Jul 26Jul 7, 25$8.32Jul 9, 25$8.72Jul 11, 25$8.55Jul 15, 25$8.27Jul 17, 25$8.14Jul 21, 25$8.29Jul 23, 25$8.04Jul 25, 25$7.90Jul 29, 25$2.97Jul 31, 25$2.74Aug 4, 25$2.83Aug 6, 25$2.62Aug 11, 25$2.43Aug 13, 25$2.51Aug 15, 25$2.49Aug 19, 25$2.36Aug 21, 25$2.53Aug 25, 25$2.45Aug 27, 25$2.35Aug 29, 25$2.31Sep 3, 25$2.32Sep 5, 25$2.34Sep 9, 25$2.42Sep 11, 25$2.44Sep 16, 25$2.35Sep 18, 25$2.45Sep 22, 25$2.68Sep 24, 25$2.59Sep 26, 25$2.52Sep 30, 25$2.58Oct 2, 25$2.49Oct 6, 25$2.52Oct 8, 25$2.42Oct 10, 25$2.37Oct 14, 25$2.49Oct 16, 25$2.45Oct 21, 25$2.45Oct 23, 25$2.40Oct 27, 25$2.46Oct 29, 25$2.24Oct 31, 25$1.98Nov 4, 25$1.50Nov 6, 25$1.57Nov 10, 25$1.47Nov 12, 25$1.48Nov 14, 25$1.33Nov 18, 25$1.33Nov 20, 25$1.30Nov 25, 25$1.59Nov 28, 25$1.52Dec 2, 25$1.39Dec 4, 25$1.47Dec 8, 25$1.52Dec 10, 25$1.45Dec 12, 25$1.37Dec 16, 25$1.38Dec 18, 25$1.36Dec 22, 25$1.40Dec 24, 25$1.28Dec 29, 25$1.32Jan 2, 26$1.19Jan 6, 26$1.30Jan 8, 26$1.34Jan 12, 26$1.25Jan 14, 26$1.31Jan 16, 26$1.34Jan 21, 26$1.17Jan 23, 26$1.20Jan 27, 26$1.21Jan 29, 26$1.15Feb 2, 26$1.21Feb 4, 26$1.06Feb 9, 26$0.97Feb 11, 26$0.84Feb 13, 26$1.25Feb 18, 26$1.19Feb 20, 26$1.05Feb 24, 26$1.07Feb 26, 26$0.99Mar 2, 26$0.77Mar 4, 26$0.69Mar 6, 26$0.69Mar 10, 26$0.70Mar 12, 26$0.68Mar 17, 26$0.71Mar 19, 26$0.92Mar 23, 26$0.96Mar 25, 26$0.85Mar 27, 26$0.70Mar 31, 26$0.58Apr 2, 26$0.59Apr 7, 26$0.55Apr 9, 26$0.52Apr 13, 26$0.53Apr 15, 26$0.55Apr 17, 26$0.55Apr 22, 26$0.53Apr 24, 26$0.52Apr 28, 26$0.52Apr 30, 26$0.52May 4, 26$0.52May 6, 26$0.48May 8, 26$0.34May 12, 26$0.29May 14, 26$0.26May 18, 26$0.41May 20, 26$0.25May 22, 26$0.24May 28, 26$0.44Jun 1, 26$0.90Jun 3, 26$0.73Jun 5, 26$0.52Jun 9, 26$0.40Jun 11, 26$0.46Jun 15, 26$0.39Jun 17, 26$0.40Jun 22, 26$0.38Jun 24, 26$0.37Jun 26, 26$0.31Jul 2, 26$0.28
$0.2352-week range$8.81
Loading valuation history…

Fundamentals

Key fundamentals

$1.3M

Market cap

-48.2%

Revenue growth (YoY)

-284.1%

Gross margin

-$11M

Free cash flow (USD)

$3.9M

Net debt

4.8%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$92.0KFY 2017$437.0KFY 2018$367.0KFY 2019$140.0KFY 2020$163.0KFY 2021$135.0KFY 2022$141.0KFY 2023$202.0KFY 2024$170.0KFY 2025$88.0K
$92K$88K

Free cash flow by year

2016 → 2025

FY 2016$-7.8MFY 2017$-8.0MFY 2018$-10.8MFY 2019$-9.4MFY 2020$-11.0MFY 2021$-14.6MFY 2022$-16.4MFY 2023$-21.9MFY 2024$-14.9MFY 2025$-11.0M
-$7.8M-$11M

Gross margin by year

2021 → 2025

FY 2021-529.6%FY 2022400.7%FY 202379.2%FY 202481.8%FY 2025-284.1%
-529.6%-284.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 15, 2026 (EPS $-0.69)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventNYSE Compliance RegainedJun 15, 2026Filing
  • 8-K eventSecurities Purchase AgreementJun 11, 2026Filing
  • 8-K eventBylaw AmendmentJun 10, 2026Filing
  • 8-K eventResearch Presentation ReleasedJun 4, 2026Filing
  • 8-K eventSecurities Purchase AgreementMay 21, 2026Filing
  • 8-K eventDebt RefinancingMay 19, 2026Filing
  • Quarterly report10-Q FiledMay 15, 2026Filing
  • 8-K eventInvestor PresentationMay 14, 2026Filing
  • 8-K eventWarrant IssuanceMay 12, 2026Filing
  • 8-K eventWarrant IssuanceMay 8, 2026Filing

Questions

Frequently asked questions

What is AIM ImmunoTech Inc.'s market cap?

AIM ImmunoTech Inc. (AIM) has a market capitalization of $1.3M.

What is AIM's P/E ratio?

A meaningful P/E ratio is not available for AIM — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

When did AIM ImmunoTech Inc. last report earnings?

AIM last reported earnings on May 15, 2026; the next date is not yet scheduled.

Are insiders buying AIM stock?

SEC Form 4 filings show no open-market insider buys at AIM ImmunoTech Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

SXTP

60 Degrees Pharmaceuticals, Inc.

$1.2M

NEXR

Nexera Technologies Ltd

$1M

CANF

Can-Fite BioPharma Ltd.

$1.8M

VRAX

Virax Biolabs Group Limited

$769K

GOVX

GeoVax Labs, Inc.

$2M

ASBP

Aspire Biopharma Holdings, Inc.

$627.6K

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.